Breaking Pakistan Tightens Foreign Media Reporting Rules, Critics Cite Press Freedom Concerns Afghan Migrant Jailed Pending Trial in Killing of Scottish Aid Worker Europe Grapples With Severe Heatwave, Record Temperatures, and Wildfires John Carpenter Unveils New Album and Graphic Novel ‘Cathedral’ Inspired by Dream Ohio Sees Renewed Focus on Mormon History Amidst Temple Milestones

Thursday August 6, 2026

Reporter

AbbVie

4Articles Published

5Communities Covered

Published Articles

Press Release

Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence

3 hours ago

Press Release

Allergan Aesthetics receives approval for Boey® (trenibotulinumtoxinE), for use in Europe: the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients

Jul 17

Press Release

SkinMedica® Deepens Commitment to Regenerative Science with Continued Investment in Research and Development

Jul 14

Press Release

AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

Jul 6